Never Run Out Of Buyers To Sell To.

Diopter Corporation has developed a proprietary medical device that combines an amniotic membrane with a biopolymer to create a single-use, bioresorbable contact lens for treating corneal wounds. This innovative technology offers a non-surgical alternative to traditional amniotic membrane surgical grafts, which have been proven effective in reducing corneal scarring, blood vessel growth, and blindness. The Diopter lens provides a new, non-surgical method for deploying the benefits of amniotic membrane surgical graft technology. The company consists of seasoned management that invented,…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.